Trials / Recruiting
RecruitingNCT07201649
Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Individuals with metabolic syndrome (MetS), particularly those with type 2 diabetes (T2D), and/or metabolic dysfunction-associated steatohepatitis or MASH face an elevated risk of major cardiovascular events (MACE). We showed decrease plams level of PPi in patients with liver cirrhosis. We hypothezised that liver transplant should block AC and restore PPi plasma level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | a blood test and urine sample collection. | The study is offered to all patients who meet the inclusion criteria during their pre-transplant assessment by the principal investigator (during an existing visit). Patients eligible for HT are contacted by a clinical research coordinator, and if they agree, an inclusion visit is arranged. |
Timeline
- Start date
- 2025-11-24
- Primary completion
- 2028-11-24
- Completion
- 2029-11-24
- First posted
- 2025-10-01
- Last updated
- 2025-12-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07201649. Inclusion in this directory is not an endorsement.